000 | 01953 a2200541 4500 | ||
---|---|---|---|
005 | 20250515080051.0 | ||
264 | 0 | _c20071010 | |
008 | 200710s 0 0 eng d | ||
022 | _a1535-2900 | ||
024 | 7 |
_a10.2146/ajhp070245 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThomas, Jennifer | |
245 | 0 | 0 |
_aBlood conservation in the critically ill. _h[electronic resource] |
260 |
_bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists _cAug 2007 |
||
300 |
_aS11-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnemia _xdrug therapy |
650 | 0 | 4 | _aBaltimore |
650 | 0 | 4 |
_aBlood _xdrug effects |
650 | 0 | 4 | _aBlood Chemical Analysis |
650 | 0 | 4 | _aClinical Protocols |
650 | 0 | 4 |
_aCritical Care _xmethods |
650 | 0 | 4 |
_aCritical Illness _xtherapy |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 | _aEpoetin Alfa |
650 | 0 | 4 |
_aErythrocyte Transfusion _xstatistics & numerical data |
650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFerric Compounds _xadministration & dosage |
650 | 0 | 4 | _aFerric Oxide, Saccharated |
650 | 0 | 4 | _aGlucaric Acid |
650 | 0 | 4 |
_aHematinics _xadministration & dosage |
650 | 0 | 4 | _aHospital Mortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntensive Care Units |
650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aMartinez, Anthony | |
773 | 0 |
_tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists _gvol. 64 _gno. 16 Suppl 11 _gp. S11-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2146/ajhp070245 _zAvailable from publisher's website |
999 |
_c17219018 _d17219018 |